Mebeverine for Pediatric Functional Abdominal Pain: A Randomized, Placebo-Controlled Trial

Table 1

Baseline characteristics of the patients.

	Mebeverine; 𝑛=44	Placebo; 𝑛=43	𝑃 value
Age, year	8.5±2.0	8.5±2.2	0.839*
Girl/boy	24 (54.5)/20 (45.4)	24 (55.8)/19 (44.1)	0.538**
Father education
0–5 y	3 (6.8)	7 (16.2)	0.660***
6–12 y	29 (65.9)	24 (55.8)
>12 y	11 (25)	12 (27.9)
Family income^†
Low income	7 (15.9)	9 (20.9)	0.492***
Middle income	25 (56.8)	26 (60.4)
High income	10 (22.7)	8 (18.6)
Pain score	3.5±1.0	3.6±0.8	0.557***
CGI-S score	4.9±1.1	5.4±0.9	0.056***

Data are presented as mean ± SD or number (%). CGI-S: Clinical Global Impression Severity. *Independent sample 𝑡-test, **Chi-square test, and ***Mann-Whitney 𝑈 test. ^†Based on the Iranian Rial currency. Two patients did not provide information on family income.